Melanotan I and II: what the literature says about these α-MSH analogs
MC1R selectivity versus non-selective MC1R/MC3R/MC4R activation: an editorial comparison of two analogs of the melanotropic hormone studied in research.
Melanotan I and Melanotan II are two synthetic analogs of α-MSH (alpha-melanocyte stimulating hormone), an endogenous hormone involved in the regulation of skin pigmentation and several hypothalamic functions. Although related, the two molecules present distinct pharmacological profiles that are extensively documented in the literature.
Melanotan I: a marked selectivity for MC1R
Melanotan I (afamelanotide) shows a preferential affinity for the MC1R receptor, expressed mainly by melanocytes. Its activation stimulates adenylate cyclase, increases intracellular cAMP and activates the MITF → tyrosinase pathway, the rate-limiting enzyme of melanogenesis. The literature (PMID 15262693, 9113347) describes an increased production of eumelanin — the most photoprotective pigment — rather than pheomelanin. Its relative selectivity for MC1R, with reduced affinity for MC3R/MC4R, limits the reported effects on appetite or sexual function compared with its non-selective analog.
Melanotan II: a non-selective agonist at four receptors
Melanotan II, on the other hand, activates the entire set of melanocortin receptors: MC1R, MC3R, MC4R and MC5R. This lack of selectivity considerably broadens the spectrum of mechanisms studied in the literature: hypothalamic activation via MC3R/MC4R (reported involvement in appetite regulation and energy expenditure), modulation of leptin secretion, and effects on hypothalamic pro-opiomelanocortin neurons regulating nitric oxide release.
A third, more selective analog: PT-141
A derivative of Melanotan II, PT-141 (Bremelanotide), was developed to refine selectivity toward MC4R/MC3R while reducing affinity for MC1R — and therefore the pigmentary effect. The literature positions it as a complementary pharmacological tool for dissociating central effects (MC4R) from peripheral pigmentary effects (MC1R) in comparative research protocols.
Why this family remains an active subject of study
Melanocortin receptors are involved in an unusually broad set of physiological functions — pigmentation, appetite, energy expenditure, sexual behavior — which explains the sustained interest of the pharmacological literature in precisely mapping the contribution of each receptor subtype using ligands of varying selectivity such as MT-1, MT-2 and PT-141.